High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer

被引:8
|
作者
Song, Li [1 ]
Xing, Aiyan [2 ]
Li, Qiuju [1 ]
Wang, Guoyun [1 ]
机构
[1] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
基金
美国国家科学基金会;
关键词
endometriosis-associated malignancy; rectal endometriosis; high-grade serous carcinoma; simultaneous primary carcinoma; ovarian cancer; ADENOCARCINOMA;
D O I
10.3389/fonc.2019.01252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometriosis is one of the most common benign gynecological diseases. It shows similar attributes to those of some fatal tumors if it is becomes malignant. These attributes include invasion, implantation, and recurrence. Epidemiological, clinicopathological, molecular biological, and genetic evidence suggest that malignancy of endometriosis, referred to as endometriosis-associated malignancy (EAM), is histologically closely related to endometriosis. Atypical endometriosis, which usually causes EAM, is considered a transitional condition from benign endometriosis to cancer. Approximately 80% of EAMs occur in the ovary and are known as endometriosis-associated ovarian cancer (EAOC). However, extragonadal endometriosis is not common, and no earlier study reported an association between malignant transformation of rectal endometriosis and high-grade serous cancer. We report a rare case of high-grade serous carcinoma resulting from rectal endometriosis and complicated with ovarian cancer. A 63-year-old Chinese woman was admitted with a complaint of abdominal distension. We diagnosed the patient with ovarian carcinoma and decided on elective cytoreductive surgery as treatment for the patient. During the surgery, we found a solid mass of diameter 12 cm in the anterior rectal wall containing sticky brown fluid. Postoperative histopathological examination revealed high-grade serous carcinoma resulting from rectal endometriosis and complicated with ovarian cancer. The patient postoperatively received 6 cycles of chemotherapy consisting of carboplatin and paclitaxel and was followed up for 1 year with no recurrence of the condition.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
    David D. Bowtell
    Steffen Böhm
    Ahmed A. Ahmed
    Paul-Joseph Aspuria
    Robert C. Bast
    Valerie Beral
    Jonathan S. Berek
    Michael J. Birrer
    Sarah Blagden
    Michael A. Bookman
    James D. Brenton
    Katherine B. Chiappinelli
    Filipe Correia Martins
    George Coukos
    Ronny Drapkin
    Richard Edmondson
    Christina Fotopoulou
    Hani Gabra
    Jérôme Galon
    Charlie Gourley
    Valerie Heong
    David G. Huntsman
    Marcin Iwanicki
    Beth Y. Karlan
    Allyson Kaye
    Ernst Lengyel
    Douglas A. Levine
    Karen H. Lu
    Iain A. McNeish
    Usha Menon
    Steven A. Narod
    Brad H. Nelson
    Kenneth P. Nephew
    Paul Pharoah
    Daniel J. Powell
    Pilar Ramos
    Iris L. Romero
    Clare L. Scott
    Anil K. Sood
    Euan A. Stronach
    Frances R. Balkwill
    Nature Reviews Cancer, 2015, 15 : 668 - 679
  • [32] Mixed high-grade serous and large cell neuroendocrine carcinoma arising from rectal endometriosis 11 years after hysterectomy
    Takumi Yanagita
    Takuto Hikichi
    Yuichi Waragai
    Hiroshi Shimizu
    Yuta Takahashi
    Naoto Abe
    Choichiro Hashimoto
    Hiromi Kumakawa
    Masao Kobayakawa
    Hiromasa Ohira
    Clinical Journal of Gastroenterology, 2023, 16 : 366 - 371
  • [33] Mixed high-grade serous and large cell neuroendocrine carcinoma arising from rectal endometriosis 11 years after hysterectomy
    Yanagita, Takumi
    Hikichi, Takuto
    Waragai, Yuichi
    Shimizu, Hiroshi
    Takahashi, Yuta
    Abe, Naoto
    Hashimoto, Choichiro
    Kumakawa, Hiromi
    Kobayakawa, Masao
    Ohira, Hiromasa
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (03) : 366 - 371
  • [34] Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
    Gilks, C. Blake
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [35] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [36] Principles of dormancy evident in high-grade serous ovarian cancer
    Trevor G. Shepherd
    Frederick A. Dick
    Cell Division, 17
  • [37] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [38] High-Grade Serous Ovarian Cancer during Pregnancy: From Diagnosis to Treatment
    Vivod, Gregor
    Merlo, Sebastjan
    Kovacevic, Nina
    CURRENT ONCOLOGY, 2024, 31 (04) : 1920 - 1935
  • [39] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02): : 136 - 145
  • [40] Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
    Chandrasekaran, G.
    Hall, D.
    Vias, M.
    Brenton, J. D.
    Gergely, F.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26